02/23/2023
The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable ...
02/16/2023
Fiscal Calendar Year Changes from June to December Year End
RICHLAND, WASHINGTON & CORALVILLE, IOWA – February
02/07/2023
Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging ...
02/06/2023
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of ...
01/30/2023
Stockholders Approve Proposal One Clearing Way for Consummation of Merger
RICHLAND, WASHINGTON – January 30, 2023 ...
01/12/2023
RICHLAND, WASHINGTON – January 12, 2023 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
12/14/2022
RICHLAND, WASHINGTON – December 14, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
11/10/2022
Revenue Increased 12% Year-Over-Year
Record Non-Prostate Brachytherapy Revenue Increased 28% ...
10/31/2022
Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – October 31, ...
10/18/2022
RICHLAND, WA and CORALVILLE, IA – October 18, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology ...
09/28/2022
RICHLAND, WASHINGTON – September 28, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
09/21/2022
Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September 21, 2022 ...
Media & Public Relations Contact
If you have questions or need help, please contact:
Chuck Padala
Public and Media Relations